Autoimmunity, Infection and Thrombosis (GRAIÏT)

INFECTION, IMMUNITY AND ENVIRONMENT
OBJECTIUS

The GRAIÏT group is made up of a multidisciplinary team of doctors, with significant clinical experience, teaching and research activity (8 doctors and 5 pre-doctoral students). It works together to expand the knowledge of autoimmune and infectious diseases. The main field of research is focused on the study of the physio pathogenic bases of these diseases with the aim to identify new biomarkers and possible therapeutic targets.

Furthermore, these diseases share elements related to a state of chronic inflammation leading to the development of metabolic alterations, cardiovascular risk and thrombotic events which mark the prognosis and morbidity and mortality of these patients.

Since 2020, GRAÏIT is also focused on the research of prognostic biomarkers and therapeutic targets in COVID-19 and persistent symptoms (post-COVID).

RESPONSABLES
  • Dr. Antoni Castro Salomó

  • Dra. Sandra Parra Pérez

  • Research lines
  • Competitive projects
  • NON-COMPETITIVE PROJECTS FINANCED IN RECENT YEARS
  • Group members
  • DOCTORAL THESES
  • RELEVANCE TO ADVISORY COMMITTEES AND/OR MEMBERS OR EXPERT GROUPS OF SCIENTIFIC SOCIETIES AND/OR OFFICIAL BODIES.
  • Publications
  • Projects
  • Contact
  • Study of cardiovascular risk and subclinical arteriosclerosis in patients with Systemic Lupus Erythematosus (SLE)
  • Investigation of subclinical atherosclerosis markers in patients with SLE (carotid intima-media thickness, endothelial function and arterial stiffness)
  • Lipidomic and proteomic study of lipoproteins in patients with SLE
  • Investigation of activity biomarkers in patients with SLE (Gelsolin)
  • Study of prognostic markers of catheter-associated infections and healthcare system infections.
  • Study of new prognostic biomarkers in patients admitted for community-acquired pneumonia (CAP) and for COVID-19. ACRONYM NAC-HDL COVID-19.
  • Gelsolin: a biomarker and potential treatment for the post-Covid patient.
  • Prognostic markers and cardiovascular risk in patients with Psoriasis
  • Prognostic biomarkers and cardiovascular risk in patients with systemic autoimmune diseases
  • Prognostic biomarkers in patients admitted to the ICU with sepsis
  • Cardiovascular risk and prognostic biomarkers in arterial hypertension

  • FUNDACIÓ MARATÓ TV3 IDENTIFICATION OF BIOMARKERS NASED ON ENERGY METABOLISM AND OXIDATIVE STRESS IN PATIENTS WITH URINARY CATHETER-ASSOCIATED INFECTIONS AND DEVELOPMENT OF BIOSENSORS FOR THEIR DETEMRINATION IN PRIMARY AND HOSPITAL CARE . J CAMPS. (FUNDACIÓ PRIVADA INVESTIGACIONS SANITARIES PERE VIRGILI). 6/3/18-18/6/21. 197.000

  • Beca de Investigación Básica 2016 de la Academia de Ciencias Médicas y de la Salud de Cataluña y Baleares, por el proyecto Efectividad de un Smartwatch en la activación del circuito de Reanimación Cardiopulmonar en pacientes con paro cardiorrespiratorio en la calle. Academia de las Ciencias Médicas de Cataluña y Baleares. Josep Basorar et al. (Instituto Catalán de la Salud) Desde 2016-actualidad. 20.000 euros.

  • SAL-OSTEOP-2010-01 (ESTUDIO FRATER) “Utilidad de la herramienta FRAX para predecir el riesgo de fractura en pacientesatendidos en consultas de reumatología en España”.

  • ROC-TOC-2011-01 (ACT-AXIS) “Estudio observacional, prospectivo, para evaluar y correlacionar el impacto del tratamiento con RoActemra® (Tocilizumab) sobre la fatiga y diferentes factores que influyen en ella en pacientes con artritis reumatoide en la práctica clínica habitual.Estudio ACT-A”

  • ABB-LOP-2010-01“Percepción del tratamiento con Kaletra (comprimidos) dosificado 1 vez al día en PacientesInfectados por VIH. Estudio TransversAL (QD-KAPITAL)”. (FINALITZAT 2012)

  • ORDI-01” Ensayo clínico aleatorizado y controlado para evaluar la eficacia de la azatioprina vs. micofenolatosódico para el tratamiento de la fase de inducción y mantenimiento de la remisión de los brotes extra renales del lupus eritematoso”.

  • NOV-ANT-2011-01“Prevalencia y manejo clínico de pacienteshospitalizadosinfectados por grampositivos con insuficiencia renal en España. Estudio Daptokidney: Fases Prevenir y Evaluar.” (ESTUDIO DAPTOKIDNEY)

  • ESTUDIO SEQUENCE “Oportunidades de secuenciación intravenosa a oral y de alta precoz en infecciones por grampositivos que precisan de tratamiento con un glucopéptido o lipopéptido”.

  • BAY-RIV-2012-01 ” XALIA Xarelto© para la Anticoagulación a Largo plazo e Inicial en el tromboembolismo venoso (TEV) “.

  • SHI-TSE-2011-01 “Estudio epidemiológico sobre el estado actual de los pacientes con enfermedad de Gaucher tipo I en España, evaluados mediante la TherapeuticGoals MAP (Monitor, ActionandProgress) Tool© “. Estudio MAPPING EG.

  • SAP-02 “rivaroxaban versus acenocumarol en la profilaxis secundaria del síndrome  tifosfolípido: un estudio multicéntrico, prospectivo y randomizado. análisis de factores de estratificaciónpronóstica de evolución clínica.”

  • BMS-ACO-2014-01 ESTUDIO PERFILAR:“Estudio multicéntrico observacional para determinar el perfil y manejo del tratamiento antitrombótico de los pacientes con fibrilación auricular no valvular que acuden a los servicios de medicina interna de los hospitales españoles” Código CV185372

  • CE01-301: Study drug Solthromycin . CEM-101 A Randomized, Double – Blind, Multi -Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM -101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients with Community -Acquired Bacterial Pneumonia

  • LCD-CDAD-10-07/11-06 A Randomized, Double-Blinded, Active-Controlled Study of CB-183, 315 in Patients with Clostridium Difficile Associated Diarrea. Cubist Pharmaceuticals.

  • Títol del projecte: Arteriosclerosis subclínica en pacientes con enfermedades sistémicas. Colección de muestras biológicas y estudio vascular en pacientes con LES en el momento inicial, a los 3 años de seguimiento y en brote clínico. IP: Antoni Castro. Inici 2006-vigent

  • TÍTOL DEL PROJECTE: (NAC-HDL) Relación entre los factores pronósticos de los pacientes ingresados por neumonía adquirida en la comunidad (NAC) y el estudio de funcionalidad y composición de las partículas de colesterol HDL IP: Sandra Parra, Antoni Castro 2012-vigent

  • ESTUDI FASE III, ALEOATORITZAT, AMB DOBLE ENMASCARAMENT I COMPRADOR ACTIU DE LA EFICACIA I LA SEGURETAT ENTRE RIDINILAZOL (200mg, 2 C/dia) DURANTE 10 DIAS I VANCOMICINA (125 mg, 4 cops/dia) DURANT 10 DIES PER AL TRACTAMENT DE LA INFECCIÓ PER CLOSTRIDIUM DIFFICILE (ICD). Antoni Castro Salomó. 15/10/2019-15/10/2022) 10.524 Euros.

  • A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept study to evaluate the Efficacy and Safety of Recombinant Human Plasma Gelsolin (rhu-pGSN) added to Standard of Care for Treatment of Subjects with Severe COVID-19 Pneumonia. BIoaegis. IP: Antoni Castro, Co_IP: Sandra parra 1/8/2020-1/8/2021. 180.000 euros.

  • Doctorand: Mireia Saballs Nadal

    Títol: Importància clínica dels nivells de colesterol HDL en l’evolució i l’aparició de complicacions en la pneumònia adquirida a la comunitat i la COVID-19.

    Any de defensa i calificació: 01/04/2025, Cum laude

    Supervisors: Antoni Castro Salomó, Sandra Parra  Pérez

  • Doctorant: Marta González

    Títol: Alterations in the metabolsim of tryglicerides in Systemic Lupus Erythematosus.

    Any de defensa i calificació: 2016, Cum Laude.

    Supervisors: Antoni Castro i Josep Rivalta, Universitat Rovira i Virgili.

  • Doctorant: Miguel Camafort Babkowski

    Títol: Artherial pressure ambulatory monitoring utility in the prognostic of patients with heart failure.

    Any de defensa i calificació: 2016, Distinction.

    Supervisor: Antoni Castro, Universitat Rovira i Virgili.

  • Doctorant: Simona Micaela Iftime

    Títol: Paraoxonase-1 in patients with catheter associated infections

    Any de defensa i calificació: 2015, Cum Laude.

    Supervisor: Antoni Castro, Universitat Rovira i Virgili.

  • Grupo de Enfermedades Autoinmunes Sistémicas (GEAS-SEMI). Sociedad Española de Medicina Interna (Antoni Castro Salomó, Sandra Parra Pérez)
  • Línea de investigación Esclerodermia-REMSCLE (Antoni Castro Salomó, Sandra Parra Pérez)
  • Registro Español de pacientes con Lupus Eritematoso Sitémico (RELES)
  • Registro Español de pacientes tratados con Belilumab (BeliLESGEAS)
  • Estudio EPINE. Estudio de prevalencia de la infección nosocomial en España
    Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by (1)H-NMR. A real-world observational study (IPE-NMR).

    Amigó N, Dalli-Peydró E, Díaz-Díaz JL, Oterino A, Cabau L, Ballestín-Ballestín J, Garcia-Moll X, Masana L. 01/11/2026

    Hepatic immune microenvironment dynamics in severe obesity and post-bariatric surgery: insights from immunohistochemical analysis

    Onoiu, AI, González-Serrano, S, Cambra-Cortés, V, Jiménez-Franco, A, Guilarte, C, Peña, KB, Riu, F, Camps, J, Joven, J, Parada, D. 03/09/2026

    Admission lipid profile and outcomes in sepsis requiring early invasive source control.

    Piris JAB, Pérez SP, Quintana PFC, Benedicto PMG, Barrios XG, Parra LC, Segarra XN, Anglès CR, Perapoch IV, Salomó AC. 15/07/2026

    Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition.

    Pavón R, Parra S, Rubio FJ, Feliu M, Ríos M, Iftimie S, Rovira C, Amigó N, Cabau L, Martínez-Micaelo N, Castro A. 03/03/2026

    Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials.

    Escrihuela-Vidal F, Larrauri JG, López-Contreras J, Euba G, Vázquez A, Gómez-Zorrilla S, López-Cortés LE, Gasch O, Aparicio-Minguijón E, Escudero-Sánchez R, Pérez-Rodríguez MT, Rodríguez-Pardo D, Jover-Sáenz A, García-Pardo G, Rodríguez-Baño J, Pujol M, Carratalà J, Gutiérrez-Gutiérrez B. 01/03/2026

    Post-Radiotherapy Changes in Circulating Dodecanoic Acid Identify Metabolic Phenotypes Associated with Recurrence in Breast Cancer.

    Jiménez-Franco A, Cambra-Cortés V, García-Pablo R, Canela-Capdevila M, Benavides-Villarreal R, Gabaldó-Barrios X, Fort-Gallifa I, Camps J, Joven J, Arenas M. 26/02/2026

    A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder Cancer.

    Parada D, Onoiu AI, Iftimie S, Camps J, Riu F, Castro A, Joven J. 02/02/2026

    ERG expression is not predictive of outcome in patients with intermediate- and high-risk localized prostate cancer treated with combined androgen blockade and radiotherapy

    Henriquez, I, Malave, B, Benitez-Gabella, G, Parada, D, Canela, M, García-Pablo, R, Benavides, R, Rius, F, Arenas, M. 01/02/2026

    Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia (Vol 418, 111606, 2025)

    Ballester, F, Gabaldo-Barrios, X, Pujol, I, Iftimie, S, Camps, J, Parra, S, Castro, A, Joven, J. 05/01/2026

    Circulating Lipid Profiles Indicate Incomplete Metabolic Recovery After Weight Loss, Suggesting the Need for Additional Interventions in Severe Obesity (vol 15, 1112, 2025)

    Onoiu, AI, Cambra-Cortés, V, Jiménez-Franco, A, Hernández-Aguilera, A, Parada, D, Riu, F, Zorzano, A, Camps, J, Joven, J. 25/12/2025

    Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia

    Ballester, F, Gabaldó-Barrios, X, Jiménez-Franco, A, Pujol, I, Iftimie, S, Camps, J, Parra, S, Castro, A, Joven, J. 05/09/2025

    Dysregulation of the FGF21-Adiponectin Axis in a Large Cohort of Patients with Severe Obesity and Liver Disease

    Castañé, H, Jiménez-Franco, A, Onoiu, AI, Cambra-Cortés, V, Hernández-Aguilera, A, Parada, D, Riu, F, Zorzano, A, Camps, J, Joven, J. 02/09/2025

    Circulating Lipid Profiles Indicate Incomplete Metabolic Recovery After Weight Loss, Suggesting the Need for Additional Interventions in Severe Obesity

    Onoiu, AI, Cambra-Cortés, V, Jiménez-Franco, A, Hernández-Aguilera, A, Parada, D, Riu, F, Zorzano, A, Camps, J, Joven, J. 01/08/2025

    Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus

    Camps, J, Iftimie, S, Jimenez-Franco, A, Castro, A, Joven, J. 16/07/2025

    Serum butyrylcholinesterase activity as a predictor of severity and mortality in COVID-19 patients

    Fazekas, T, Kovaik, L, Rad, MM, Barrios, XG, Iftimie, SM, Camps, J, Hrabovská, A. 02/07/2025

    Jordans' anomaly in Chanarin-Dorfman syndrome

    Sánchez-Cortés, J, Gabaldó-Barrios, X. 28/03/2025

    Oral antibiotic prophylaxis induces changes in the microbiology of surgical site infection after colorectal surgery. A matched comparative study.

    Flores-Yelamos M, Juvany M, Badia JM, Vázquez A, Pascual M, Parés D, Almendral A, Limón E, Pujol M, Gomila-Grange A. 01/02/2025

    Evaluating the use of Uromune® autovaccine in recurrent urinary tract infections: a pilot unicenter retrospective study in Reus, Spain

    Iftimie, S, Ladero-Palacio, P, López-Azcona, AF, Pujol-Galarza, L, Pont-Salvadó, A, Gabaldó-Barrios, X, Joven, J, Camps, J, Castro, A, Pascual-Queralt, M. 24/01/2025

    Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis

    Castañé, H, Jiménez-Franco, A, Hernández-Aguilera, A, Martínez-Navidad, C, Cambra-Cortés, V, Onoiu, AI, Jiménez-Aguilar, JM, Paris, M, Hernández, M, Parada, D, Guilarte, C, Zorzano, A, Hernández-Alvarez, MI, Camps, J, Joven, J. 01/01/2025

    The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic Testing in Familial Hypercholesterolemia

    Daiana, I, Didac, L, Celia, RB, Natalia, A, Nuria, P, Roberto, S, Ana, GL, Nuria, A, Josefa, G, Lluis, M. 23/01/2024

    Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field

    Di Giacomo-Barbagallo, F, Andreychuk, N, Scicali, R, Gonzalez-Lleo, A, Piro, S, Masana, L, Ibarretxe, D. 01/12/2024

    Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction-associated steatotic liver disease

    Arto, C, Rusu, EC, Clavero-Mestres, H, Barrientos-Riosalido, A, Bertran, L, Mahmoudian, R, Aguilar, C, Riesco, D, Chicote, JU, Parada, D, Martinez, S, Sabench, F, Richart, C, Auguet, T. 01/11/2024

    Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study

    Iznardo, H, Roé, E, Vicente, A, Prat, C, Casals, M, Martín-Santiago, A, Esteve, A, Viñas, M, Munera-Campos, M, Corella, F, Mollet, J, Figueras-Nart, I, Vila, A, Soria, X, Azón-Masoliver, A, Marqués-Martín, L, Nadal-Lladó, C, Bel, S, Pujol-Montcusí, J, Bertolín-Colilla, M, Curto-Barredo, L, Melé-Ninot, G, Evole, M, Berbegal, L, Puig, L, Baselga, E. 30/10/2024

    Differential analysis of lipoprotein and glycoprotein profiles in bacterial infections and COVID-19 using proton nuclear magnetic resonance and machine learning

    Iftimie, S, Amigó, N, Martínez-Micaelo, N, López-Azcona, AF, Martínez-Navidad, C, Castañé, H, Jiménez-Franco, A, Ribalta, J, Parra, S, Castro, A, Camps, J, Joven, J. 15/09/2024

    Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia

    Saballs, M, Parra, S, Martínez, N, Amigo, N, Cabau, L, Iftimie, S, Pavon, R, Gabaldó, X, Correig, X, Paredes, S, Vallvé, JM, Castro, A. 01/09/2024

    FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY

    Costa, E, Paredes, S, Taverner, D, Pàmies, A, Tomas, C, Llop, D, Llop, C. 01/08/2024

    Contributing to the management of viral infections through simple immunosensing of the arachidonic acid serum level

    Torrente-Rodríguez, RM, Montiel, VRV, Iftimie, S, Montero-Calle, A, Pingarrón, JM, Castro, A, Camps, J, Barderas, R, Campuzano, S, Joven, J. 01/07/2024

    Serum Levels of Arachidonic Acid, Interleukin-6, and C-Reactive Protein as Potential Indicators of Pulmonary Viral Infections: Comparative Analysis of Influenza A, Respiratory Syncytial Virus Infection, and COVID-19

    Iftimie, S, Gabaldó-Barrios, X, Penadés-Nadal, J, Canela-Capdevila, M, Piñana, R, Jiménez-Franco, A, López-Azcona, AF, Castañé, H, Cárcel, M, Camps, J, Castro, A, Joven, J. 01/07/2024

    External Validation of the Machine Learning-Based Thermographic Indices for Rheumatoid Arthritis: A Prospective Longitudinal Study

    Morales-Ivorra, I, Taverner, D, Codina, O, Castell, S, Fischer, P, Onken, D, Martínez-Osuna, P, Battioui, C, Marín-López, MA. 01/07/2024

    Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay

    Bernet-Vegué, L, Cantero-González, C, de Salas, MS, Parada, D, Perin, T, Quintero-Niño, Z, Pérez-Quintela, BV, Sánchez-Guzman, D, Castelvetere, M, Hernaez, DH, Martín-Salvago, MD. 01/05/2024

    Changes in oxidative stress and the inflammatory system in breast cancer patients

    Avila, VDC, Franco, AJ, Capdevila, MC, Pablo, RG, Aguilar, JMJ, Casta , H, Mora, PA, Chac n, BAM, Benitez, G, Acosta, JC, Benavides, R, Troncho, CE, Engel, O, Parada, D, De la Flor, M, Jord , C, Mel , M, Repkova, J, Prat, MA. 01/05/2024

    Retrospective Analysis of Clostridioides difficile Infection Rates and Outcomes in Hospitalized Patients during the COVID-19 Pandemic: A Unicenter Study in Reus, Spain

    Iftimie, S, López-Azcona, AF, Corchero-Valverde, M, Peralta-Vázquez, A, López-Cordón, LR, García-Cervera, C, Fernández-Domínguez, LM, Camps, J, Joven, J, Castro, A. 01/05/2024

    Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis

    Freire, M, Sopeña, B, González-Quintela, A, del Castillo, AG, Moraga, EC, Lledó-Ibañez, GM, Rubio-Rivas, M, Trapiella, L, Argibay, A, Tolosa, C, Alfonso, BM, Vargas-Hitos, JA, Salas, XP, González-Echávarri, C, Chamorro, AJ, Fraile, IP, García, AG, Bellvis, GD, Bello, DB, Salomo, AC, de Heredia, IJP, Marín-Ballve, A, Rodríguez-Píntó, I, Saez-Comet, L, Ortego-Centeno, N, Todolí-Parra, JA, Pla, VF, Simeón-Aznar, CP. 01/05/2024

    Assessing the Utility of Multiplexed Polymerase Chain Reaction in Detecting Microorganisms Causing Infections in Critically ill Patients

    Garrido, P, Gabaldó-Barrios, X, Pujol-Bajador, I, Fernández, L, Ballester, F, Garrido, R, Cueto, P, Camps, J, Vallverdu, I. 01/11/2023

    Plasma Expression of Carotid Plaque Presence-Related MicroRNAs Is Associated with Inflammation in Patients with Rheumatoid Arthritis

    Llop, D, Paredes, S, Ibarretxe, D, Taverner, D, Plana, N, Rosales, R, Masana, L, Vallvé, JC. 01/10/2023

    Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer

    Fernández-Castillejo, S, Roig, B, Melé, M, Serrano, S, Salvat, M, Querol, M, Brunet, J, Pineda, M, Cisneros, A, Parada, D, Badia, J, Borràs, J, Rodríguez-Balada, M, Gumà, J. 17/08/2023

    Paraoxonase-1: How a xenobiotic detoxifying enzyme has become an actor in the pathophysiology of infectious diseases and cancer

    Camps, J, Iftimie, S, Arenas, M, Castañé, H, Jiménez-Franco, A, Castro, A, Joven, J. 01/08/2023

    Blood Liquid Biopsy in an Advanced Medullary Thyroid Carcinoma: A Case Study with Rearranged during Transfection Heterogeneity

    Gumà, J, Peña, KB, Riu, F, Lucia-Gozálvez, C, Vidaller, A, Maldonado, V, Parada, D. 01/08/2023

    The concentrations of essential/toxic elements in serum of COVID-19 patients are not directly related to the severity of the disease

    Marquès, M, Iftimie, S, Camps, J, Joven, J, Domingo, JL. 01/07/2023

    Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease

    Parra, S, Saballs, M, DiNubile, M, Feliu, M, Iftimie, S, Revuelta, L, Pavón, R, Avila, A, Levinson, S, Castro, A. 01/06/2023

    Study of Liquid-Based Cytology Using Next-Generation Sequencing as a Liquid Biopsy Application in Patients with Advanced Oncological Disease

    Peña, KB, Riu, F, Hernandez, A, Guilarte, C, Elizalde-Horcada, M, Parada, D. 01/06/2023

    A panel of plasma microRNAs improves the assessment of surrogate markers of cardiovascular disease in rheumatoid arthritis patients

    Llop, D, Ibarretxe, D, Plana, N, Rosales, R, Taverner, D, Masana, L, Vallvé, JC, Paredes, S. 03/04/2023

    Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain

    Iftimie, S, López-Azcona, AF, Lozano-Olmo, MJ, Naval-Ferrando, A, Domingo-Cortés, V, Castañé, H, Jiménez-Franco, A, Hernández-Aguilera, A, Guilarte, C, Riu, F, Camps, J, Joven, J, Castro, A. 01/04/2023

    SARS-CoV-2 Serum Viral Load and Prognostic Markers Proposal for COVID-19 Pneumonia in Low-Dose Radiation Therapy Treated Patients

    Piqué, B, Peña, K, Riu, F, Acosta, JC, Torres-Royo, L, Malave, B, Araguas, P, Benavides, R, De Febrer, G, Camps, J, Joven, J, Arenas, M, Parada, D. 01/02/2023

    Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity

    Barrientos-Riosalido, A, Real, M, Bertran, L, Aguilar, C, Martinez, S, Parada, D, Vives, M, Sabench, F, Riesco, D, Castillo, DD, Richart, C, Auguet, T. 10/01/2023

    Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19

    Baiges-Gaya, G, Iftimie, S, Castañé, H, Rodríguez-Tomàs, E, Jiménez-Franco, A, López-Azcona, AF, Castro, A, Camps, J, Joven, J. 01/01/2023

    Melanoma-specific survival is worse in the elderly: a multicentric cohort study

    Segura, S, Podlipnik, S, Boada, A, Marti, RM, Sabat, M, Yélamos, O, Zarzoso-Muñoz, I, Azón-Masoliver, A, López-Castillo, D, Solà, J, Baliu-Piqué, C, Galvany-Rossell, L, Pasquali, P, Just-Sarobé, M, Duran, X, Carrera, C, Richarz, NA, Pujol, RM, Malvehy, J, Puig, S. 01/12/2023

    Report on the first two confirmed autochthonous cases of West Nile virus encephalitis in Catalonia, Spain

    García-Cervera, C, Iftimie, SM, Martínez, MJ, González, AV, Parra-Pérez, S, Revuelta-López-Cordón, L, Gil-Toral, J, Vallverdú, RMV, Mateo, AM, López-Azcona, AF, Pujol-Bajador, I, Ballester-Bastardie, F, Castro-Salomó, A. 02/11/2023

    Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Grillo, S, Pujol, M, Miró, JM, López-Contreras, J, Euba, G, Gasch, O, Boix-Palop, L, Garcia-País, MJ, Pérez-Rodríguez, MT, Gomez-Zorrilla, S, Oriol, I, López-Cortés, LE, Pedro-Botet, ML, San-Juan, R, Aguado, JM, Gioia, F, Iftimie, S, Morata, L, Jover-Sáenz, A, García-Pardo, G, Loeches, B, Izquierdo-Cárdenas, A, Goikoetxea, AJ, Gomila-Grange, A, Dietl, B, Berbel, D, Videla, S, Hereu, P, Padulles, A, Pallarès, N, Tebé, C, Cuervo, G, Carratalà, J, SAFO Study Grp. 01/10/2023

    Treatment of COVID-19 pneumonia with low-dose radiotherapy plus standard of care versus standard of care alone in frail patients The SEOR-GICOR IPACOVID comparative cohort trial

    Arenas, M, Piqué, B, Torres-Royo, L, Acosta, JC, Rodríguez-Tomàs, E, De Febrer, G, Vasco, C, Araguas, P, Gómez, JA, Malave, B, Arquez, M, Algara, M, Montero, A, Montero, M, Simó, JM, Gabaldó, X, Parada, D, Riu, F, Sabater, S, Camps, J, Joven, J. 01/09/2023

    Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients

    Capdevila, O, Mitjavila, F, Espinosa, G, Caminal-Montero, L, Marín-Ballvè, A, León, RG, Castro, A, Canora, J, Pinilla, B, Fonseca, E, Ruiz-Irastorza, G, Autoimmune Dis Study Grp GEAS. 01/08/2023

    Treatment of COVID-19 pneumonia with low-dose radiotherapy in frail patients

    Chacon, BAM, Arteaga, JCA, Piqué, B, Torres-Royo, L, Rodríguez-Tomás, E, Benavides, R, De Febrer, G, Araguas, P, Gomez, JA, Arquez, M, Calderon, VD, Algara, M, Montero, A, Parada, D, Riu, F, Jiménez, A, Vasco, C, Sabater, S, Camps, J, Joven, J, Prat, MA. 01/05/2023

    Reactive ileal lymphoid hyperplasia related to SARS-CoV-2 infection as a unique clinical feature resembling Crohn's disease

    Qanneta, R, Feliu-Masgoret, M, García-Pardo, G, Marimon-Cortés, F. 01/02/2023

    Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study

    Peña, KB, Riu, F, Gumà, J, Martínez-Madueño, F, Miranda, MJ, Vidal, A, Grifoll, M, Badia, J, Rodriguez-Balada, M, Parada, D. 01/12/2022

    Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples

    Gumà, J, Peña, K, Riu, F, Guilarte, C, Hernandez, A, Lucía, C, Martínez-Madueño, F, Miranda, MJ, Cabezas, I, Grifoll, M, Peralta, S, Serrano, S, Muñoz, F, Delamo, L, Roig, B, Borràs, J, Badia, J, Rodriguez-Balada, M, Parada, D. 01/12/2022

    The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract

    Galceran, J, Parada, D, Eden, M, Tumino, R, Warren, AY, Martos, C, Neamtiu, L, Visser, O, Daubisse-Marliac, L. 23/11/2022

    Characteristics of hospitalized patients with SARS-CoV-2 infection during successive waves of the COVID-19 pandemic in a reference hospital in Spain

    Iftimie, S, López-Azcona, AF, Lozano-Olmo, MJ, Hernández-Aguilera, A, Sarrà-Moretó, S, Joven, J, Camps, J, Castro, A. 17/10/2022

    Measurement of Plasma Galectin-3 Concentrations in Patients with Catheter Infections: A Post Hoc Retrospective Cohort Study

    Iftimie, S, Hernández-Aguilera, A, López-Azcona, AF, Castañé, H, Rodríguez-Tomàs, E, Baiges-Gaya, G, Camps, J, Castro, A, Joven, J. 01/10/2022

    Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia

    DiNubile, MJ, Parra, S, Salomó, AC, Levinson, SL. 02/08/2022

    Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019)

    Badia-Cebada, L, Peñafiel, J, López-Contreras, J, Pomar, V, Martínez, JA, Santana, G, Cuquet, J, Montero, MM, Hidalgo-López, C, Andrés, M, Gimenez, M, Quesada, MD, Vaqué, M, Iftimie, S, Gudiol, C, Pérez, R, Coloma, A, Marron, A, Barrufet, P, Marimon, M, Lérida, A, Clarós, M, Ramírez-Hidalgo, MF, Pardo, GG, Martinez, MJ, Chamarro, EL, Jiménez-Martínez, E, Hornero, A, Limón, E, López, M, Calbo, E, Pujol, M, Gasch, O. 01/08/2022

    Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19

    Gabaldó, X, Juanpere, M, Castañé, H, Rodríguez-Tomàs, E, López-Azcona, AF, Baiges-Gaya, G, Castro, L, Valverde-Díaz, E, Muñoz-Blázquez, A, Giménez-Cuenca, L, Felipo-Balada, L, Ballester, F, Pujol, I, Simó, JM, Castro, A, Iftimie, S, Camps, J, Joven, J. 01/07/2022

    Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells-An Institutional Study

    Peña, KB, Riu, F, Hernandez, A, Guilarte, C, Badia, J, Parada, D. 01/07/2022

    Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain

    Colmenero, M, del Boz, J, Wittel, JB, Roé, E, Feito-Rodríguez, M, Vicente-Villa, MA, Martín-Santiago, A, Pérez, SIP, Azon, A, Valdivielso-Ramos, M, Torrelo, A, Moya, AIS, Campos-Domínguez, M, Garnacho-Saucedo, G, Defez, JMA, Casaño, AV, Tercedor-Sánchez, J, Alcalá, R, González-Enseyat, MA, Giacaman, A, Hernández-Martin, A, García, MTM, Bauzá, A, Domínguez-Cruz, J, García-Doval, I, Grau-Pérez, M. 01/07/2022

    Immunocytochemical Assessment of ACE2 and TMPRSS2 in Nasopharyngeal Swabs from SARS-CoV-2 Patients

    Peña, KB, Gumà, J, Guilarte, C, Delamo, L, Grifol, M, Pique, B, Hernandez, A, Casteñé, H, Riu, F, Parada, D. 24/06/2022

    Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia

    Rodríguez-Tomàs, E, Acosta, JC, Torres-Royo, L, De Febrer, G, Baiges-Gaya, G, Castañé, H, Jiménez, A, Vasco, C, Araguas, P, Gómez, J, Malave, B, Arquez, M, Calderón, D, Piqué, B, Algara, M, Montero, A, Simó, JM, Gabaldó-Barrios, X, Sabater, S, Camps, J, Joven, J, Arenas, M. 01/06/2022

    EFFECTS OF INHIBITOR K-CARRAGEENAN ON HAECS INFLAMMATORY RESPONSE TO LDLS ISOLATED FROM SLE PATIENTS

    Parra, S, Avila, A, Rivalta, J, Guardiola, M, Rodriguez, R, Castro, A. 01/06/2022

    FATIGUE IN RHEUMATOID ARTHRITIS: DOES PATIENT AGE INFLUENCE?

    Rodriguez-Muguruza, S, Castro, S, Poveda, MJ, Paredes, S, Taverner, D, Fontova, R. 01/06/2022

    Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients

    Castañé, H, Iftimie, S, Baiges-Gaya, G, Rodríguez-Tomás, E, Jiménez-Franco, A, López-Azcona, AF, Garrido, P, Castro, A, Camps, J, Joven, J. 01/06/2022

    Clinical Outcome and Radiologic Changes in SARS-CoV-2 Pneumonia treated with Low-Dose Radiotherapy.

    Arteaga, JCA, Royo, LT, Rodríguez-Tomás, E, De Febrer, G, Vasco, C, Gomez, JA, Araguas, P, Malave, B, Arquez, M, Algara, M, Montero, A, Montero, M, Simo, JM, Gavaldà, X, Pique, B, Parada, D, Sabater, S, Camps, J, Joven, J, Arenas, M. 01/05/2022

    Can COVID-19 vaccines relieve severe tension-type headache and migraine?

    González-Menacho, J, Villas-Roca, M, Castañé, H, Joven, J, Camps, J, Iftimie, S. 01/04/2022

    Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?

    Daubisse-Marliac, L, Grosclaude, P, Carulla, M, Parada, D, Vilardell, L, Ameijide, A, Marcos-Gragera, R, Galceran, J. 01/03/2022

    Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease

    Moreno-Vedia, J, Rosales, R, Ozcariz, E, Llop, D, Lahuerta, M, Benavent, M, Rodriguez-Calvo, R, Plana, N, Pedragosa, A, Masana, L, Castro, A, Ibarretxe, D, Girona, J. 10/01/2022

    Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men

    Rehues, P, Rodríguez, M, Alvarez, J, Jiménez, M, Melià, A, Sempere, M, Balsells, C, Castillejo, G, Guardiola, M, Castro, A, Ribalta, J. 01/01/2022

    Association Among Polyphenol Intake, Uric Acid, and Hyperuricemia: A Cross-Sectional Analysis in a Population at High Cardiovascular Risk

    Rubín-García, M, Vitelli-Storelli, F, Alvarez-Alvarez, L, Martínez-González, MA, Salas-Salvadó, J, Corella, D, Hernáez, A, Martínez, JA, Alonso-Gómez, AM, Wärnberg, J, Vioque, J, Romaguera, D, López-Miranda, J, Estruch, R, Tinahones, FJ, Serra-Majem, LI, Cano-Ibañez, N, Tur, JA, Marcos-Delgado, A, Tresserra-Rimbau, A, Pintó, X, Delgado-Rodríguez, M, Matía-Martín, P, Vidal, J, Vázquez, C, Daimiel, L, Ros, E, Vázquez-Ruiz, Z, Babio, N, Barragán, R, Castañer-Niño, O, Razquin, C, Tojal-Sierra, L, Gómez-Gracia, E, González-Palacios, S, Morey, M, García-Rios, A, Castro-Barquero, S, Bernal-López, MR, Santos-Lozano, JM, Ruiz-Canela, M, Castro-Salomó, A, Pascual-Castelló, EC, Moldon, V, Bullón-Vela, V, Sorto-Sanchez, C, Cenoz-Osinaga, JC, Gutiérrez, L, Mengual, M, Lamuela-Raventós, RM, Martín-Sánchez, V. 18/10/2022

    Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)

    Carbonell, C, Marcos, M, Guillén-Del-Castillo, A, Rubio-Rivas, M, Argibay, A, Marín-Ballvé, A, Rodríguez-Pintó, I, Baldà-Masmiquel, M, Callejas-Moraga, E, Colunga, D, Sáez-Comet, L, González-Echávarri, C, Ortego-Centeno, N, Marí-Alfonso, B, Vargas-Hitos, JA, Todolí-Parra, JA, Trapiella, L, Herranz-Marín, MT, Freire, M, Castro-Salomó, A, Perales-Fraile, I, Madroñero-Vuelta, AB, Sánchez-García, ME, Ruiz-Muñoz, M, González-García, A, Sánchez-Redondo, J, De-la-Red-Bellvis, G, Fernández-Luque, A, Muela-Molinero, A, Lledó, GM, Tolosa-Vilella, C, Fonollosa-Pla, V, Chamorro, AJ, Simeón-Aznar, CP. 01/10/2022

  • Title: 2021 SGR 01018 GRUP DE RECERCA CONSOLIDAT (GRC) OPCIO RECONEIXEMENT SENSE FINANÇAMENT (VALIDACIO TECNICA) URV-IISPV – PV23071S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2022-2025

    Principal Investigator: CASTRO SALOMO, ANTONI

  • Title: AYUDA FEA 2023 – SANDRA PARRA DESARROLLO DE UNA NUEVA HERRAMIENTA DE PRONOSTICO PARA LA SALUD CARDIOVASCULAR EN MUJERES JOVENES QUE SUFREN LES UTILIZANDO UN ENFOQUE OMICO Y LA INTEGRACION DE DATOS A TRAVES DE ALGORITMOS DE APRENDIZAJE AUTOMATICO/INTELIGENCIA ARTIFICIAL (SLEVASC) – PV24023S

    Funding entity: FUNDACION ESPAÑOLA DE ARTERIOESCLEROSIS

    Duration: 2024-2025

    Principal Investigator: PARRA PÉREZ , SANDRA

Membres De L’equip